{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:47:29Z","timestamp":1759333649670,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.jaad.2007.12.040","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T17:37:28Z","timestamp":1206466648000},"page":"781-786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Acne and oral contraceptives: Update on women's health screening guidelines"],"prefix":"10.1016","volume":"58","author":[{"given":"Jason E.","family":"Frangos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina N.","family":"Alavian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa B.","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.12.040_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2006.08.048","article-title":"Guidelines of care for acne vulgaris management","volume":"56","author":"Strauss","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.12.040_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2007.12.040_bib3","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2007.12.040_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/cjwh.2001.25638","article-title":"Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in the treatment of moderate acne vulgaris","author":"Maloney","year":"2001","journal-title":"Clin J Women's Health"},{"journal-title":"Yaz package insert","year":"2007","author":"Bayer HealthCare Pharmaceuticals","key":"10.1016\/j.jaad.2007.12.040_bib5"},{"issue":"1","key":"10.1016\/j.jaad.2007.12.040_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004425.pub3","article-title":"Combined oral contraceptive pills for treatment of acne","author":"Arowojolu","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"year":"1999","series-title":"Oral contraceptives for adolescents: benefits and safety","author":"American College of Obstetricians and Gynecologists","key":"10.1016\/j.jaad.2007.12.040_bib7"},{"year":"2004","series-title":"Expert Working Group Meeting to Update the Selected Practice Recommendations for Contraceptive Use. Selected practice recommendations for contraceptive use","key":"10.1016\/j.jaad.2007.12.040_bib8"},{"key":"10.1016\/j.jaad.2007.12.040_bib9","first-page":"27","article-title":"Faculty of Family Planning and Reproductive Health Care, Royal College of Obstetricians and Gynaecologists. First prescription of combined oral contraceptions: recommendations for clinical practice","volume":"26","year":"2000","journal-title":"Br J Fam Plann"},{"key":"10.1016\/j.jaad.2007.12.040_bib10","unstructured":"Society of Obstetricians and Gynaecologists of Canada. Canadian Contraception Consensus. Clinical practice guidelines No. 143- part 2. Available at: http:\/\/sogc.medical.org\/guidelines\/public\/143E-CPG2-March2004.pdf. Accessed October 2007."},{"key":"10.1016\/j.jaad.2007.12.040_bib11","unstructured":"IMAP statement on contraception for adolescents\/young people in the era of HIV and AIDS. Available at: http:\/\/www.ippf.org\/NR\/rdonlyres\/54B782C7-E761-4A76-8687-1A2B9D5C2CFB\/0\/IMAPstatementjune2006.pdf. Accessed October 2007."},{"year":"1994","series-title":"Recommendations for updating selected practices in contraceptive use, volume I","author":"World Health Organization and U.S. Agency for International Development","key":"10.1016\/j.jaad.2007.12.040_bib12"},{"key":"10.1016\/j.jaad.2007.12.040_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2307\/2673737","article-title":"Provision of hormonal contraceptives without a mandatory pelvic examination: the first stop demonstration project","volume":"33","author":"Harper","year":"2001","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.jaad.2007.12.040_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/1054-139X(94)90262-3","article-title":"SMART START: an option for adolescents to delay the pelvic examination and blood work in family planning clinics","volume":"15","author":"Armstrong","year":"1994","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jaad.2007.12.040_bib15","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1001\/jama.285.17.2232","article-title":"Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence","volume":"285","author":"Stewart","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2007.12.040_bib16","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJMoa035419","article-title":"Risk of cervical cancer associated with extending the interval between cervical-cancer screenings","volume":"349","author":"Sawaya","year":"2003","journal-title":"N Engl J Med"},{"issue":"76","key":"10.1016\/j.jaad.2007.12.040_bib17","first-page":"15","article-title":"Screening for squamous cervical cancer\u2014the duration of low risk following negative results in cervical cytology test: Introduction. IARC Working Group on Cervical Cancer Screening","year":"1986","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.jaad.2007.12.040_bib18","first-page":"593","article-title":"Accuracy of the pelvic examination in detecting adnexal masses","volume":"96","author":"Padilla","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2007.12.040_bib19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1370\/afm.200","article-title":"Screening for ovarian cancer: recommendation statement","volume":"2","author":"U.S. Preventive Services Task Force","year":"2004","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jaad.2007.12.040_bib20","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/00006250-200612000-00061","article-title":"ACOG Committee Opinion No. 357: Primary and preventive care: periodic assessments","volume":"108","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2007.12.040_bib21","first-page":"237","article-title":"ACOG practice bulletin. cervical cytology screening. No. 45","volume":"83","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jaad.2007.12.040_bib22","unstructured":"US Preventive Services Task Force. USPSTF screening for cervical cancer. Available at: http:\/\/www.ahrq.gov\/clinic\/3rduspstf\/cervcan\/cervcanrr.htm. Accessed October 2007."},{"key":"10.1016\/j.jaad.2007.12.040_bib23","first-page":"342","article-title":"ACS guideline for the early detection of cervical neoplasia and cancer","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaad.2007.12.040_bib24","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.12.040_bib25","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"FUTURE II Study Group","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.12.040_bib26","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":"Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials","volume":"369","author":"Joura","year":"2007","journal-title":"Lancet"},{"issue":"RR-2","key":"10.1016\/j.jaad.2007.12.040_bib27","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2007.12.040_bib28","first-page":"905","article-title":"ACOG practice bulletin. Clinical Management Guidelines for Obstetrician-gynecologists. No. 61, April 2005. Human papillomavirus","volume":"105","author":"American College of Obstetricians and Gynecologists","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"RR-11","key":"10.1016\/j.jaad.2007.12.040_bib29","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2006","volume":"55","author":"Workowski","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2007.12.040_bib30","unstructured":"US Preventive Services Task Force. Screening for gonorrhea: recommendation statement. 2005. Available at: http:\/\/www.ahrq.gov\/clinic\/uspstf05\/gonorrhea\/gonrs.htm. Accessed October 2007."},{"key":"10.1016\/j.jaad.2007.12.040_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/0003-4819-147-2-200707170-00172","article-title":"Screening for chlamydial infection: U.S. Preventive Services Task Force Recommendation Statement","volume":"147","author":"U.S. Preventive Services Task Force","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2007.12.040_bib32","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMcp030751","article-title":"Clinical practice. Combination estrogen-progestin oral contraceptives","volume":"349","author":"Petitti","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.12.040_bib33","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"ACOG Practice Bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions","volume":"107","author":"ACOG Committee on Practice Bulletins-Gynecology","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2007.12.040_bib34","first-page":"93","article-title":"ACOG practice bulletin. The use of hormonal contraception in women with coexisting medical conditions. Number 18","volume":"75","author":"ACOG Committee on Practice Bulletins-Gynecology","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"year":"2003","series-title":"Improving access to quality care in family planning: Medical eligibility criteria for contraceptive use","author":"World Health Organization","key":"10.1016\/j.jaad.2007.12.040_bib35"},{"key":"10.1016\/j.jaad.2007.12.040_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(97)00118-2","article-title":"The use of oral contraceptives and the occurrence of acute myocardial infarction in young women: results from the transnational study on oral contraceptives and the health of young women","volume":"56","author":"Lewis","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2007.12.040_bib37","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","article-title":"Oral contraceptives and the risk of myocardial infarction","volume":"345","author":"Tanis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.12.040_bib38","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.12.040_bib39","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.STR.0000015345.61324.3F","article-title":"Risk of arterial thrombosis in relation to oral contraceptives (RATIO) study: Oral contraceptives and the risk of ischemic stroke","volume":"33","author":"Kemmeren","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jaad.2007.12.040_bib40","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(95)12393-8","article-title":"Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.12.040_bib41","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/1097-0215(20011120)95:6<370::AID-IJC1065>3.0.CO;2-T","article-title":"Low-dose oral contraceptives: protective effect on ovarian cancer risk","volume":"95","author":"Royar","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2007.12.040_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/aje\/152.3.233","article-title":"Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE study group. Steroid Hormones and Reproductions","volume":"152","author":"Ness","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"2 Suppl","key":"10.1016\/j.jaad.2007.12.040_bib43","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1067\/mob.2001.117416","article-title":"Current perspectives on oral contraceptive use","volume":"185","author":"Burkman","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2007.12.040_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0010-7824(83)90009-4","article-title":"The effects of three different regimens of oral contraceptives and three different intrauterine devices on the levels of hemoglobin, serum iron and iron binding capacity in anemic women","volume":"27","author":"Rivera","year":"1983","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2007.12.040_bib45","first-page":"913","article-title":"Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding","volume":"96","author":"Davis","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2007.12.040_bib46","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.jaad.2007.12.040_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004","volume":"95","author":"Vessey","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2007.12.040_bib48","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","article-title":"Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC Multicentric Case-control Study","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.12.040_bib49","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(03)12949-2","article-title":"Cervical cancer and use of hormonal contraceptives: a systematic review","volume":"361","author":"Smith","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.12.040_bib50","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.AOG.0000254165.92653.e8","article-title":"Cervical cancer incidence in a prevaccine era in the United States, 1998-2002","volume":"109","author":"Saraiya","year":"2007","journal-title":"Obstet Gynecol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208001357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208001357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:10:15Z","timestamp":1759270215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962208001357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0190962208001357"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.12.040","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acne and oral contraceptives: Update on women's health screening guidelines","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.12.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}